Recall Register

Device recall: cobas e801 Immunoassay Analyzer

Class II FDA enforcement event 90657. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Roche Diagnostics Operations, Inc. started this device recall on 14 Jul 2022. The firm address in the FDA record is in Indianapolis, IN. FDA put the recall in Class II. FDA event 90657 has 1 product record. The first FDA enforcement report date is 17 Aug 2022. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI,…

Recalling firm

Roche Diagnostics Operations, Inc., Indianapolis, IN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 90657: product records
Recall numberProductQuantityClassStatusReport date
Z-1515-2022cobas e801 Immunoassay Analyzer965 unitsClass IIOngoing17 Aug 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2022
839
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
69

Other events of the firm

Other FDA enforcement events of Roche Diagnostics Operations, Inc.
InitiatedProduct (first record)TypeClassRecords
20 Jan 2026cobas pro integrated solutions with cobas c 503 analytical units: cobas pro sample supply unit, material number 08464502DeviceClass II1
21 Nov 2025The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated microparticles and elDeviceClass II1
17 Oct 2024cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test forDeviceClass II1
15 Aug 2024Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determinaDeviceClass II1
3 Oct 2023Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 31DeviceClass II1
12 Dec 2022cobas infinity central lab, Material Number 07154003001DeviceClass II1
18 Oct 2021Cobas u 601 urinalysis test system, Catalog number 06334601001 The cobas U 601 urinalysis test system is comprised of thDeviceClass II1
24 Jun 2021cobas infinity central lab running software version 3.01.03 through 3.02.08, Catalog#: 07154003001DeviceClass II1
26 Apr 2021IRON GEN 2: ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES, Catalog#: 03183696122 - Product Usage: In vitro test for thDeviceClass II1
7 Apr 2021Elecsys Troponin I STAT Immunoassay: Catalog# 05094798160 - Product Usage: intended to aid in the diagnosis of myocardiaDeviceClass II2

Roche Diagnostics Operations, Inc.: all 69 events

Official channels

Cite this page

Recall Register. FDA enforcement event 90657. https://recallregister.com/fda/ii/90657/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI,…
What quantity of product is in FDA event 90657?
The FDA record gives this quantity: 965 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2022 have the same class?
88% of the 839 device events that started in 2022 are in Class II.